0001829255-22-000001.txt : 20221230 0001829255-22-000001.hdr.sgml : 20221230 20221230121904 ACCESSION NUMBER: 0001829255-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 EFFECTIVENESS DATE: 20221230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Halia Therapeutics, Inc. CENTRAL INDEX KEY: 0001829255 IRS NUMBER: 822679083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469248 FILM NUMBER: 221501123 BUSINESS ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: 801-753-5707 MAIL ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 D 1 primary_doc.xml X0708 D LIVE 0001829255 Halia Therapeutics, Inc. 1865 West 2100 South Suite 100 Salt Lake City UT UTAH 84119 (385) 355-4315 DELAWARE None None Corporation true 2017 Jeffrey Burton 1865 West 2100 South Suite 100 Salt Lake City UT UTAH 84119 Executive Officer David Bearss 1865 West 2100 South Suite 100 Salt Lake City UT UTAH 84119 Executive Officer Director Jared Bearss 1865 West 2100 South Suite 100 Salt Lake City UT UTAH 84119 Director John S.K. Kauwe 1865 West 2100 South Suite 100 Salt Lake City UT UTAH 84119 Director Jim Savas 1865 West 2100 South Suite 100 Salt Lake City UT UTAH 84119 Director Biotechnology Decline to Disclose 06b false 2022-12-16 false true false 0 49999991 12223338 37776653 false 24 0 0 0 false Halia Therapeutics, Inc. Jeffrey Burton Jeffrey Burton Chief Financial Officer 2022-12-30